e-learning
resources
Munich 2014
Sunday, 07.09.2014
Biomarkers of asthma and clinical immunology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The clinical and genetic factors for predicting the response to inhaled corticosteroids
H. Nagase, N. Tsurikisawa, E. Matsui, N. Kondo, K. Akiyama, K. Ohta (Tokyo, Sagamihara, Gifu, Japan)
Source:
International Congress 2014 – Biomarkers of asthma and clinical immunology
Session:
Biomarkers of asthma and clinical immunology
Session type:
Thematic Poster Session
Number:
1037
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Nagase, N. Tsurikisawa, E. Matsui, N. Kondo, K. Akiyama, K. Ohta (Tokyo, Sagamihara, Gifu, Japan). The clinical and genetic factors for predicting the response to inhaled corticosteroids. Eur Respir J 2014; 44: Suppl. 58, 1037
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Evaluating omalizumab persistency of response after long-term therapy (XPORT)
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Features of asthma treatment while pregnancy
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Efficacy of omalizumab in Polish real-world patients
Source: International Congress 2016 – Asthma management
Year: 2016
Influence of maternal bronchial asthma clinical phenotype on development of allergies in children
Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors
Year: 2014
Lung function response to omalizumab in severe allergic asthma patients in UK clinical practice: APEX II study
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
The impact of sublingual allergen-specific therapy on asthma control and quality of life
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Development of binary forecast models of asthma exacerbation: Asthma index
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Genetic polymorphisms in early and late-onset bronchial asthma
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
When needed use of inhaled steroids in children with asthma
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Association between control of rhinitis and control of asthma as assessed by validated questionnaires
Source: International Congress 2014 – Clinical allergy
Year: 2014
Patterns of clinical use of omalizumab in Spain: A 5-year "real-life" study
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Fungal sensitization in patients with moderate and severe asthma
Source: International Congress 2014 – Clinical allergy
Year: 2014
Study of psychiatric comorbidities in patients with bronchial asthma
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Clinical effectiveness of anti-IgE therapy in severe asthma with fungus sensitization
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Investigating the role of BAFF in murine models of allergic asthma
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
Combined therapy of asthma and allergic rhinitis
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Asthma clusters in a real asthmatic population, treated in secondary medical care
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Omalizumab reduces exacerbations and healthcare utilisation in severe allergic asthma patients UK clinical practice - APEX II study
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Serious asthma exacerbations in a hospital setting
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept